A carregar...
Nebivolol Efficacy and Safety in Patients with Stage I‐II Hypertension
BACKGROUND: Nebivolol is a novel, β(1)‐adrenergic receptor blocker with vasodilatory properties mediated through activation of the L‐arginine/nitric oxide pathway. HYPOTHESIS: This multicenter, double‐blind, parallel‐group, placebo‐controlled study investigated the antihypertensive efficacy and safe...
Na minha lista:
| Publicado no: | Clin Cardiol |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wiley Periodicals, Inc.
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6653317/ https://ncbi.nlm.nih.gov/pubmed/20162736 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.20508 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|